DK154072B - Process for preparing 1-isopropylamino-3-(4-(2- methoxyethyl)phenoxy)-2-propanol or acid addition salts thereof - Google Patents

Process for preparing 1-isopropylamino-3-(4-(2- methoxyethyl)phenoxy)-2-propanol or acid addition salts thereof Download PDF

Info

Publication number
DK154072B
DK154072B DK504879AA DK504879A DK154072B DK 154072 B DK154072 B DK 154072B DK 504879A A DK504879A A DK 504879AA DK 504879 A DK504879 A DK 504879A DK 154072 B DK154072 B DK 154072B
Authority
DK
Denmark
Prior art keywords
compound
formula
acid addition
reacted
isopropylamino
Prior art date
Application number
DK504879AA
Other languages
Danish (da)
Other versions
DK154072C (en
DK504879A (en
Inventor
Soini Kanerva Huhta
Arto Johannes Karjalainen
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK504879A publication Critical patent/DK504879A/en
Publication of DK154072B publication Critical patent/DK154072B/en
Application granted granted Critical
Publication of DK154072C publication Critical patent/DK154072C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

iin

DK 154072 BDK 154072 B

Opfindelsen angår en hidtil ukendt fremgangsmåde til fremstilling af l-isopropylamino-3-(4-*(2-methoxyethyl)--phenoxy)-2-propanol eller metoprolol med formlen IThe invention relates to a novel process for the preparation of 1-isopropylamino-3- (4 - * (2-methoxyethyl) phenoxy) -2-propanol or metoprolol of formula I

OH CH3 'OH CH3 '

CH„0 - CH„ - CH7 .J/nY. 0 - CH„ - CH -CH~ - NH - CH ICH₂O - CH₂ - CH7 .J / nY. 0 - CH2 - CH -CH2 - NH - CH1

2 2\2/ 2 2 ch3 eller additionssalte deraf.2 2 \ 2/2 2 ch3 or addition salts thereof.

Forbindelsen er et terapeutisk værdifuldt såkaldt β-receptorblokerende middel. De fleste β-receptorblokeren-de midler har den ulempe, at de foruden hjertets β-recep-5 torer også blokerer β-receptorerne i blodkar og lunger.The compound is a therapeutically valuable so-called β-receptor blocking agent. Most β-receptor blocking agents have the disadvantage that, in addition to the β-receptors of the heart, they also block the β-receptors in blood vessels and lungs.

Den omhandlede forbindelse er derimod hjertespecifik og er derfor et vigtigt lægemiddel i hjerteterapien.The compound in question, on the other hand, is heart-specific and is therefore an important drug in cardiac therapy.

Fremstillingen af den omhandlede forbindelse er f.eks, kendt fra svensk patentskrift nr. 354.851, hvor 10 der beskrives 12 analogimetoder til fremstilling deraf.The preparation of the subject compound is known, for example, from Swedish Patent Specification No. 354,851, wherein 10 discloses 12 analogous methods for the preparation thereof.

Disse metoder har det tilfælles, at de alle henføres til en fremgangsmåde til syntetisering af isopropylaminoside-kæden.These methods have in common that they are all referred to a method for synthesizing the isopropylaminoside chain.

Fremgangsmåden ifølge opfindelsen er ejendommelig ved.The process according to the invention is peculiar.

15 det i krav lfs kendetegnende del anførte. En forbindelse med formlen II _15, the characterizing part of claim 1. A compound of formula II

X - CH2 - CH2~\0/ °Na IIX - CH2 - CH2 ~ \ 0 / ° Na II

hvor X betegner en reaktionsdygtig esterrest, kan omsættes med epichlorhydrin med formlen IIIwherein X represents a reactive ester residue may be reacted with epichlorohydrin of formula III

/°\/ ° \

Cl - CH2 - CH - CH2 τιιCl - CH2 - CH - CH2 τιι

til en forbindelse med formlen IVfor a compound of formula IV

X ‘ CH2 ' - CH2 - CH · ivX 'CH2' - CH2 - CH · iv

DK 154072 BDK 154072 B

22

som derefter ifølge opfindelsen omsættes med et surt additionssalt af isopropylamin til en forbindelse med formlen Vwhich is then reacted according to the invention with an acid addition salt of isopropylamine to a compound of formula V

OH CH3OH CH3

X - CH2 - cH2YQVo - CH2 - CH - CH2 - NHCH VX - CH2 - cH2YQVo - CH2 - CH - CH2 - NHCH V

ch3 og denne forbindelse omsættes endelig med alkalimetal-meth-oxid eller med methanol i nærværelse af en sur katalysator til et slutprodukt med formlen I.and this compound is finally reacted with alkali metal methoxide or with methanol in the presence of an acidic catalyst to a final product of formula I.

Fremgangsmåden kan beskrives ved følgende formelskema : 0 \ C1-CH„-CH-CH0The process can be described by the following formula: 0 \ C1-CH2 -CH-CHO

Δ 1 OΔ 1 O

X-CH2-CH2-^^-ONa -> X~CH2-CH2-^^- 0-CH2-CH-CH2X - CH2 - CH2 - ^^ - ONa -> X ~ CH2-CH2 - ^^ - O-CH2-CH-CH2

II IVII IV

OH. & Θ ch3^ °H T3 Na0CH3 -> X-CH2-CH2-^(JV 0-CH2-CH-CH2-NH-CH --->OH. & Θ ch3 ^ ° H T3 NaOCH3 -> X-CH2-CH2 - ^ (JV O-CH2-CH-CH2-NH-CH --->

* or H+ and CH-DH* or H + and CH-DH

ch3 3ch3 3

VV

_ OH CH3OH CH3

CH30-CH2-CH2-0^)V 0-CH2-CH-CH2-NH-CHCH30-CH2-CH2-O) V O-CH2-CH-CH2-NH-CH

ch3CH3

Den reaktionsdygtige esterrest X kan være en alkyl-eller arylsulfonatgruppe, med fordel en tosylgruppe, idet forbindelsen IV er l,2-epoxy-3-(4-tosyloxyethylphenoxy)--propan, som er en hidtil ukendt organisk forbindelse medThe reactive ester residue X may be an alkyl or arylsulfonate group, advantageously a tosyl group, the compound IV being 1,2-epoxy-3- (4-tosyloxyethylphenoxy) propane which is a novel organic compound having

DK 154072BDK 154072B

0 30 3

formlen VIIformula VII

CH3^^)‘ji‘0~CH2_CH2^D)"D-CH2-CH-CH2 VIICH3 +) D-CH2-CH2 ^ D) D-CH2-CH-CH2 VII

eller X er et halogenatom, med fordel et chloratom, idet forbindelsen V! er l-isopropylamino-3-(4-(2-chlorethyl)--phenoxy)-2-propanol, som er en hidtil ukendt organisk forbindelse med formlen VIor X is a halogen atom, advantageously a chlorine atom, the compound V! is 1-isopropylamino-3- (4- (2-chloroethyl) phenoxy) -2-propanol which is a novel organic compound of formula VI

OH CH3OH CH3

Cl-CH2~CH2-^^n-0-CH2-CH-CH2-NH-CH VICl-CH2 ~ CH2 - ^^ n-O-CH2-CH-CH2-NH-CH VI

ch3CH3

Isopropylamin-syreadditionssaltet kan f.eks. være isopropylamino-hydrochlorid med formlen CHo ^ Λ 3X 00 CHNI-LC1 eller det kan f.eks, være isopropylamin-p-toluensulfonsyre-salt med formlen CH □ d © e ii 0The isopropylamine acid addition salt may e.g. may be isopropylamino hydrochloride of the formula CH 2 O 3 X 00 CHNI-LC 1 or it may be, for example, isopropylamine p-toluenesulfonic acid salt of the formula CH

Alkalimetalmethoxiderne kan f.eks, være kalium- eller natriummethoxid, især natriummethoxid. Ved omsætning af methanol med forbindelser med formlen V er f.eks. tør HCl-gas eller p-toluensulfonsyre hensigtsmæssige syrekata-5 lysatorer.For example, the alkali metal methoxides may be potassium or sodium methoxide, especially sodium methoxide. When reacting methanol with compounds of formula V, e.g. dry HCl gas or p-toluenesulfonic acid suitable acid catalysts.

Fremgangsmåden ifølge opfindelsen kan specielt være ejendommelig ved, at den sidste del af syntesekæden henføres til methoxyethylenden af molekylet, altså reaktionen mellem forbindelsen V og natriummethoxid eller mellem for-The process of the invention may be particularly peculiar in that the last part of the synthesis chain is attributed to the methoxyethyl end of the molecule, i.e. the reaction between the compound V and sodium methoxide or between the process.

DK 154072 BDK 154072 B

4 bindeisen V og methanol i nærværelse af en sur katalysator. Særlig ejendommeligt for fremgangsmåden ifølge opfindelsen kan det endvidere være, at forbindelsen V er specifikt fremstillet af forbindelsen IV ved omsætning af sidstnævn-5 te forbindelse under neutrale betingelser med et isopropyl-amin-syreadditionssalt. Endvidere kan det være ejendommeligt for fremgangsmåden, at udtrykkelig ved anvendelse af de ovenfor beskrevne syntesereaktioner er råmaterialerne til syntesen af slutproduktet billige og let tilgængelige, 10 og hele syntesen er derfor økonomisk.4 the binding ice V and methanol in the presence of an acidic catalyst. Further, particularly peculiar to the process of the invention, it may be that Compound V is specifically prepared from Compound IV by reaction of the latter compound under neutral conditions with an isopropyl-amino acid addition salt. Furthermore, it may be peculiar to the process that explicitly using the synthesis reactions described above, the raw materials for the synthesis of the final product are cheap and readily available, and therefore the entire synthesis is economical.

Omsætningen af isopropylaminens sure additionssalt med en forbindelse med formlen IV, er en specifik opfindelse, hvor altså isopropylaminens sure additionssalt reagerer med en forbindelse med formlen IV, er en specifik 15 reaktion med molekylets epoxidende. Det er naturligvis nødvendigt, at reaktionen er specifik til hindring af, at iso-propylamingruppen reagerer med den reaktionsdygtige esterrest. Denne specificitet opnås overraskende, idet det viser sig, at molekylets epoxidgruppe åbnes på den rette måde al-20 lerede under neutrale betingelser med sure additionssalte af isopropylamin. Reaktionen kan udføres ved, at man kombinerer udgangsmaterialerne og blander dem i et passende opløsningsmiddel, til reaktionen er afsluttet. Til acceleration er det fordelagtigt at koge reaktionsblandingen. Hen-25 sigtsmæssige opløsningsmidler er f.eks, alkoholer såsom ethanol og isopropanol.The reaction of the acid addition salt of the isopropylamine with a compound of formula IV is a specific invention in which the acid addition salt of the isopropylamine reacts with a compound of formula IV is a specific reaction with the epoxide end of the molecule. Of course, the reaction is specific to prevent the isopropylamine group from reacting with the reactive ester residue. This specificity is surprisingly obtained in that it appears that the epoxide group of the molecule is properly opened or altered under neutral conditions with acidic addition salts of isopropylamine. The reaction can be carried out by combining the starting materials and mixing them in a suitable solvent until the reaction is complete. For acceleration, it is advantageous to boil the reaction mixture. Suitable solvents are, for example, alcohols such as ethanol and isopropanol.

Det sidste reaktionstrin, hvor altså f.eks, natri-ummethoxid omsættes med forbindelsen V, udføres med fordel ved, at man koger i et passende opløsningsmiddel såsom me-30 thanol, dimethylformamid, dimethylsulfoxid eller en blanding deraf.The last reaction step, in which case, for example, sodium methoxide is reacted with the compound V, is advantageously carried out by boiling in a suitable solvent such as methanol, dimethylformamide, dimethylsulfoxide or a mixture thereof.

Mr reaktionen udføres med sur katalyse, omsættes f.eks. tilsvarende tosylatderivater med methanol i et passende opløsningsmiddel såsom methanol ved blandingens koge-35 punkt i nærværelse af en sur katalysator. Passende syrekatalysatorer er f.eks. saltsyre eller p-toluensulfonsyre.The reaction is carried out with acid catalysis, e.g. corresponding tosylate derivatives with methanol in a suitable solvent such as methanol at the boiling point of the mixture in the presence of an acidic catalyst. Suitable acid catalysts are e.g. hydrochloric or p-toluenesulfonic acid.

Det første trin i reaktionsskemaet udføres ved kon-The first step of the reaction scheme is carried out by

DK 154072 BDK 154072 B

5 ventionelle metoder, f.eks. ud fra det tilsvarende natrium-phenolatderivat og epichlorhydrin i alkohol, f.eks. ethanol, ved 20-30°C under omrøring.5 ventional methods, e.g. from the corresponding sodium phenolate derivative and epichlorohydrin in alcohol, e.g. ethanol, at 20-30 ° C with stirring.

Yed fremgangsmåden ifølge opfindelsen er det ikke 5 nødvendigt at isolere og rense mellemprodukterne til opnå else af et rent slutprodukt, og fremgangsmåden er således enkel, også i industriel målestok.By the process of the invention, it is not necessary to isolate and purify the intermediates to obtain a pure final product, and thus the process is simple, even on an industrial scale.

Den fremkomne amin I kan let overføres til sure additionssalte ved omsætning deraf med uorganiske eller or-10 ganiske syrer.The resulting amine I can be readily transferred to acidic addition salts by reaction thereof with inorganic or organic acids.

Nedenstående eksempler illustrerer fremgangsmåden.The following examples illustrate the procedure.

DK 154072 BDK 154072 B

66

Eksempel 1.Example 1.

a) 1.2-epoxy-3-(4-tosyloxyethylphenoxy )-propan (forprodukt).a) 1,2-Epoxy-3- (4-tosyloxyethylphenoxy) propane (preproduct).

2,6 g natrium opløses i 200 ml absolut ethanol.Dissolve 2.6 g of sodium in 200 ml of absolute ethanol.

26 g p-toluensulfonsyre-2-(4-hydroxyphenyl)-ethylester 5 og 10 g epichlorhydrin tilføres og omrøres 25 timer ved ca. 25°C, Blandingen hældes i vand, og produktet ekstra-heres med methylenchlorid, som tørres med natriumsulfat. Opløsningsmidlet afdestilleres i vakuum, hvorved man får l,2-epoxy-3-(4-tosyloxyethylphenoxy)-propan i form af en 10 olie.26 g of p-toluenesulfonic acid 2- (4-hydroxyphenyl) ethyl ester 5 and 10 g of epichlorohydrin are added and stirred for 25 hours at ca. 25 ° C. The mixture is poured into water and the product is extracted with methylene chloride which is dried over sodium sulfate. The solvent is distilled off in vacuo to give 1,2-epoxy-3- (4-tosyloxyethylphenoxy) propane as an oil.

b) l-isopropylamino-3-(4-tosyloxyethylphenoxy)-2-propanol- h.ydrochlorid.b) 1-Isopropylamino-3- (4-tosyloxyethylphenoxy) -2-propanol hydrochloride.

Olien fra forrige trin opløses i ethanol, og 11 g isopropylamin-hydrochlorid tilføres og koges 10 timer.The oil from the previous step is dissolved in ethanol and 11 g of isopropylamine hydrochloride is added and boiled for 10 hours.

15 Opløsningsmidlet afdampes, hvorved man får 1-isopropyl- amino-3-(4-tosyloxyethylphenoxy)-2-propanolhydrochlorid.The solvent is evaporated to give 1-isopropylamino-3- (4-tosyloxyethylphenoxy) -2-propanol hydrochloride.

c) l-isopropylamino-3-(4-(2-methoxyeth.vl)-phenoxy)-2-propanol.c) 1-Isopropylamino-3- (4- (2-methoxyethyl) phenoxy) -2-propanol.

Inddampningsresten fra forrige trin opløses i le-20 thanol, og 50 ml 30^’s natriummethoxid i methanol og 30 ml dimethylformamid tilsættes. Blandingen koges 20 timer, og opløsningsmidlet afdampes. Resten opsamles i vand, og produktet ekstraheres med chloroform. Chloroformekstrakten vaskes med vand, tørres med natriumsulfat og inddampes til 25 tørhed. Inddampningsresten består af metoprololbase, som efter omkrystallisation af f.eks, heptan har sap. 45°C.The residue from the previous step is dissolved in lithanol and 50 ml of 30 M sodium methoxide in methanol and 30 ml of dimethylformamide are added. The mixture is boiled for 20 hours and the solvent is evaporated. The residue is collected in water and the product is extracted with chloroform. The chloroform extract is washed with water, dried over sodium sulfate and evaporated to dryness. The evaporation residue consists of metoprolol base, which after recrystallization of, for example, heptane has sap. 45 ° C.

Heraf fremstilles tartrat i vinsur acetone. Metoprolol-tar-tratets smp, er 120°C.Of this, tartrate is made in tartaric acid acetone. The mp of the metoprolol tar funnel is 120 ° C.

30 Eksempel 2.Example 2.

Man går frem som i eksempel i, men med den forskel, at en ækvivalent mængde 4-(2-chlorethyl)-phenol benyttes i stedet for 4-hydroxyphenylethanoltosylat.Proceed as in Example I, but with the difference that an equivalent amount of 4- (2-chloroethyl) phenol is used instead of 4-hydroxyphenylethanol tosylate.

DK 154072 BDK 154072 B

77

Eksempel 5.Example 5

l-isoprop.vlamino-5-(4-(2-methox.yeth.yl)-phenox,y)-2 ^-propanol.1-isopropylamino-5- (4- (2-methoxyethyl) phenoxyl, y) -2β-propanol.

l-isopropylamino-3-(4-tosyloxyethylphenoxy)-2-pro-5 panol-hydrochlorid; fremstillet ifølge eksempel 1, punkt b), opløses i methanol. Een fremkomne opløsning gøres sur med hydrogenchloridgas og koges 20 timer, Methanolet afdampes, og resten opløses i vand, Yandopløsningen vaskes med toluen og gøres alkalisk med natriumhydroxid. Produktet ekstrahe-10 res med chloroform, tørres med natriumsulfat, og chloroformet afdampes. Eésten er metoprololbase, som omdannes til tartrat i vinsur acetone. Eet fremkomne tartrat har smp.1-isopropylamino-3- (4-tosyloxyethylphenoxy) -2-propanol hydrochloride; prepared according to Example 1, point b), dissolved in methanol. The resulting solution is acidified with hydrogen chloride gas and boiled for 20 hours, the methanol is evaporated and the residue is dissolved in water, the Yand solution is washed with toluene and made alkaline with sodium hydroxide. The product is extracted with chloroform, dried with sodium sulfate and the chloroform evaporated. The first is metoprolol base which is converted to tartrate in tartaric acid acetone. One resulting tartrate has m.p.

120°C.120 ° C.

Claims (5)

1. Fremgangsmåde til fremstilling af 1-isopropyl-amino-3-(4-(2-methoxyethyl)-phenoxy)-2-propanol med formlen I GH CH3 ch3d-ch2-ch2-^^-o-ch2-ch-ch2-nh-ch i ch3 eller farmaceutisk acceptable syreadditionssalte deraf, kendetegnet ved, at en forbindelse med formlen . IV D X-CH2-CH2^0-CH2-CH-CH2 IV hvor X er en reaktionsdygtig esterrest såsom en alkyl- eller arylsulfonatgruppe eller et halogenatom, omsættes med et isopropylaminsyreadditionssalt til en forbindelse med formlen V □H CH3 X-CH2-CH2-^^^-0-CH2-CH-CH2-WH-CH v hvor X har samme betydning som ovenfor, hvorefter denne forbindelse omsættes med et alkalimetalmethoxid eller med methanol i nærværelse af en sur katalysator til en forbindelse med formlen I.A process for the preparation of 1-isopropylamino-3- (4- (2-methoxyethyl) phenoxy) -2-propanol of formula I GH CH3 ch3d-ch2-ch2 - ^^ - o -ch2-ch-ch2 -nh-ch in ch 3 or pharmaceutically acceptable acid addition salts thereof, characterized in that a compound of the formula. IV D X-CH 2 -CH 2 O-CH 2 -CH-CH 2 IV wherein X is a reactive ester residue such as an alkyl or arylsulfonate group or a halogen atom is reacted with an isopropylaminic acid addition salt to a compound of formula V □ H CH 3 X-CH 2 -CH 2 Wherein X has the same meaning as above, after which this compound is reacted with an alkali metal methoxide or with methanol in the presence of an acidic catalyst for a compound of formula I. 2. Premgangsmåde ifølge krav 1, kendeteg net ved, at isopropylaminsyreadditionssaltet er et hydro- chlorid, idet'forbindelsens formel ér CHq 3-^ © Θ CHNhLCl CH3 eller et p-toluensulfonsyresalt, idet forbindelsens formel er DK 154072 B ch3^. © O li /^\ ........................... " / CHNH3 °-f,-<Q)-CH3 ch3 . 0 **VThe process according to claim 1, characterized in that the isopropylamic acid addition salt is a hydrochloride, the formula of the compound being CH 2 - 3- (CHNhLCl CH 3) or a p-toluenesulfonic acid salt, the compound of the compound being DK 154072 B ch 3 © O li / ^ \ ........................... "/ CHNH3 ° -f, - <Q) -CH3 ch3. 0 * * V 3. Fremgangsmåde ifølge krav 1, kendetegnet ved, at isopropylaminsyreadditionssaltet omsættes under neutrale betingelser med en forbindelse med formlen IT til en forbindelse med formlen V.Process according to claim 1, characterized in that the isopropylamine acid addition salt is reacted under neutral conditions with a compound of formula IT to a compound of formula V. 4. Fremgangsmåde ifølge krav 1, kendeteg net ved, at en forbindelse med formlen Y omsættes med et alkalimethoxid, fortrinsvis natriummethoxid, til en forbindelse med formlen I«Process according to claim 1, characterized in that a compound of formula Y is reacted with an alkali methoxide, preferably sodium methoxide, to a compound of formula I 5. Fremgangsmåde ifølge krav 1, kendeteg-10 net ved, at en forbindelse med formlen V omsættes med methanol i nærværelse :af en sur katalysator..Process according to claim 1, characterized in that a compound of formula V is reacted with methanol in the presence of an acidic catalyst.
DK504879A 1978-11-29 1979-11-28 METHOD FOR PREPARING 1-ISOPROPYLAMINO-3- (4- (2-METHOXYETHYL) -PHENOXY) -2-PROPANOL OR ACID ADDITION SALTS THEREOF DK154072C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI783646A FI58909C (en) 1978-11-29 1978-11-29 REFERENCE FOR THERAPEUTIC ACTIVATION OF THERAPEUTIC ACTIVATING OF 1-ISOPROPYLAMINO-3- (4- (2-METHOXYETHYL) -PHENOXY) -2-PROPANOL OCH DESS SYRAADDITIONSSALTER
FI783646 1978-11-29

Publications (3)

Publication Number Publication Date
DK504879A DK504879A (en) 1980-05-30
DK154072B true DK154072B (en) 1988-10-10
DK154072C DK154072C (en) 1989-03-06

Family

ID=8512188

Family Applications (1)

Application Number Title Priority Date Filing Date
DK504879A DK154072C (en) 1978-11-29 1979-11-28 METHOD FOR PREPARING 1-ISOPROPYLAMINO-3- (4- (2-METHOXYETHYL) -PHENOXY) -2-PROPANOL OR ACID ADDITION SALTS THEREOF

Country Status (5)

Country Link
DK (1) DK154072C (en)
FI (1) FI58909C (en)
NL (1) NL7908669A (en)
NO (1) NO793871L (en)
SE (1) SE443779B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101665441B (en) * 2009-09-18 2013-04-10 安徽省庆云医药化工有限公司 Method for preparing l-betaxolol hydrochloride
CN102381995B (en) * 2010-08-31 2015-04-15 扬子江药业集团北京海燕药业有限公司 Preparation method of metoprolol

Also Published As

Publication number Publication date
FI58909B (en) 1981-01-30
FI58909C (en) 1981-05-11
NO793871L (en) 1980-05-30
NL7908669A (en) 1980-06-02
SE443779B (en) 1986-03-10
DK154072C (en) 1989-03-06
FI783646A (en) 1980-05-30
DK504879A (en) 1980-05-30
SE7909816L (en) 1980-05-30

Similar Documents

Publication Publication Date Title
FI62829B (en) FOERFARANDE FOER FRAMSTAELLNING AV FENOLETRAR ANVAENDBARA SAOSOM CEECES
US4564628A (en) Substituted 2-aminotetralins
NO792020L (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE PHENYL PIPERAZINES
EP0168505B1 (en) Substituted 2-aminotetralins and processes for synthesis
CS197300B2 (en) Method of producing new 1-/isoquinoline-1-one-2-yl and 1,2,3,4-tetrahydrobenzazepine-1-one-2-ylalkyl/ phenyl-et
WO1998000389A1 (en) 2-hydroxypropionic acid derivative and its manufacturing method
FI69835C (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA 3-NDOLYL-TERTIAERBUTYLAMINOPROPANOLDERIVAT
DK154072B (en) Process for preparing 1-isopropylamino-3-(4-(2- methoxyethyl)phenoxy)-2-propanol or acid addition salts thereof
DK149847B (en) ANALOGY PROCEDURE FOR PREPARING AMINOAL COXYPHENYL DERIVATIVES OF ISOQUINOLINON OR NAPTHYRIDINON
SU843733A3 (en) Method of preparing derivatives of aminopropanol or their salts (its versions)
CN106928030A (en) The method that hydroxytyrosol is prepared using organo-metallic compound
DK151256B (en) METHOD OF ANALOGY FOR THE PREPARATION OF ALKYLENDIOXYBENZENE DERIVATIVES
PL110007B1 (en) Method of producing new two-substituted phenol ethers of 3-amino-2-hydroxypropane
DK161143B (en) Process for preparing beta-((2-methylpropoxy)methyl)-N- phenyl-N-(phenylmethyl)-1-pyrrolidineethaneamine hydrochloride hydrate
CA1041098A (en) 1-(3-(naphthyl-1-yl-oxy)-propyl)-piperazine derivatives
FI59985C (en) PROFESSIONAL PROTECTION FOR THERAPEUTIC ACTIVATION 1-ISOPROPYLAMINO-3- (4- (2-METHOXYTHYL) PHENOXY) -2-PROPANOL SAMT DESS SYRA ADDITIONAL SALT
NO144212B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE ARYLAL CYLAMINES
DK157865B (en) PROCEDURE FOR THE PREPARATION OF RANITIDINE AND ETHYLENIMINO DERIVATIVES FOR USE AS THE PRESENT MATERIAL OF THE PROCEDURE
DK153144B (en) METHOD FOR PREPARING 1-ISOPROPYLAMINO-3- (4- (2-METHOXYETHYL) -PHENOXY) -2-PROPANOL OR ACID ADDITION SALTS THEREOF
JPS623150B2 (en)
FI79296C (en) Process for the preparation of 1- (2,4-dichlorophenoxy) -3- (3,4-dimethoxy-phenethylamino) -propanol- (2)
CA1248537A (en) Substituted 2-amino tetralins and processes for synthesis
RU1132505C (en) HYDROCHLORIDES OF 5-PHENOXYMETHYL-1,2,3-OXADIAZOL DERIVATIVES HAVING β AND a - ADRENOLITHYC ACTIVITY
DK141964B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF ISOQUINOLINE DERIVATIVES OR SALTS THEREOF WITH PHYSIOLOGICALLY ACCEPTABLE ACIDS
DK145079B (en) METHOD FOR PREPARING 1-ISOPROPYLAMINO-3- (4- (2-METHOXYETHYL) -PHENOXY) -2-PROPANOL OR ACID ADDITION SALTS THEREOF

Legal Events

Date Code Title Description
PBP Patent lapsed